The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
Open accessAbstract
BACKGROUND: The aim of this study was to elucidate the prognostic impact of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and aldehyde dehydrogenase-1 (ALDH1) in colorectal cancer. METHODS: A tissue microarray of 1420 primary colorectal cancers and 57 normal mucosa samples was immunostained for CD133, CD166, CD44s, EpCAM, and ALDH1 in addition to 101 corresponding whole tissue sections. Invasive potential of three colorectal cancer cell lines was tested. RESULTS: Differences between normal tissue and cancer were observed for all markers (P<0.001). Loss of membranous CD166 and CD44s were linked to higher pT (P=0.002, P=0.014), pN (P=0.004, P=0.002), an infiltrating growth pattern (P<0.001, P=0.002), and worse survival (P=0.015, P=0.019) in univariate analysis only. Loss of membranous EpCAM expression was also linked to higher pN (P=0.023) and infiltrating growth pattern (P=0.005). The CD44s, CD166, and EpCAM expression were lost towards the invasive front. The CD44-/CD166- cells from three colorectal cancer cell lines exhibited significantly higher invasive potential in vitro than their positive counterparts. CONCLUSIONS: Loss, rather than overexpression, of membranous CD44s, CD166, and EpCAM is linked to tumour progression. This supports the notion that the membranous evaluation of these proteins assessed by immunohistochemistry may be representative of their cell adhesion rather than their intra-cellular functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668 · cited 5×
“METHODS: A tissue microarray of 1420 primary colorectal cancers and 57 normal mucosa samples was immunostained for CD133, CD166, CD44s, EpCAM, and ALDH1 in addition to 101 corresponding whole tissue sections.”
InfluentialCancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Phenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Migrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., & Boman, B. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4418 · Cited by 1,045
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Zhou, B.-B. S., Zhang, H., Damelin, M., Geles, K. G., Grindley, J. C., & Dirks, P. B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2137 · Cited by 841
A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCER
Jass, J. R., Love, S. B., & Northover, J. M. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90552-6 · Cited by 701
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.3.co;2-# · Cited by 609
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.0.co;2-f · Cited by 581
Epithelial Cell Adhesion Molecule
Trzpis, M., McLaughlin, P. M. J., de Leij, L. M. F. H., & Harmsen, M. C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070152 · Cited by 578
Brabletz, T., Hlubek, F., Spaderna, S., Schmalhofer, O., Hiendlmeyer, E., Jung, A., & Kirchner, T. (2005) · Cells Tissues Organs · doi:10.1159/000084509 · Cited by 528
Tumour budding in colorectal carcinoma
Prall, F. (2007) · Histopathology · doi:10.1111/j.1365-2559.2006.02551.x · Cited by 369
CD133 expression is an independent prognostic marker for low survival in colorectal cancer
Horst, D., Kriegl, L., Engel, J., Kirchner, T., & Jung, A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604664 · Cited by 311
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
Mulder, J.-W. R., Sewnath, M., Offerhaus, G., Pals, S., Oosting, J., Kruyt, P., Weidema, W., & Seldenrijk, C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90290-9 · Cited by 309
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
Weichert, W., Knösel, T., Bellach, J., Dietel, M., & Kristiansen, G. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.016238 · Cited by 264
Ep-CAM overexpression in breast cancer as a predictor of survival
Gastl, G., Spizzo, G., Obrist, P., Dünser, M., & Mikuz, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03312-2 · Cited by 262
Zlobec, I., Steele, R., Terracciano, L., Jass, J. R., & Lugli, A. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044537 · Cited by 225
Self-citationPrognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
Horst, D., Kriegl, L., Engel, J., Kirchner, T., & Jung, A. (2009) · Cancer Investigation · doi:10.1080/07357900902744502 · Cited by 209
Choi, D., Lee, H. W., Hur, K. Y., Kim, J. J., Park, G.-S., Jang, S.-H., Song, Y. S., Jang, K.-S., & Paik, S. S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2258 · Cited by 203
The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation
Albini, A., & Benelli, R. (2007) · Nature Protocols · doi:10.1038/nprot.2006.466 · Cited by 201
Zlobec, I., Lugli, A., Baker, K., Roth, S., Minoo, P., Hayashi, S., Terracciano, L., & Jass, J. R. (2007) · The Journal of Pathology · doi:10.1002/path.2164 · Cited by 143
Self-citationKristiansen, G., Pilarsky, C. P., Wissmann, C., Stephan, C., Weißbach, L., Loy, V., Loening, S. A., Dietel, M., & Rosenthal, A. (2002) · The Prostate · doi:10.1002/pros.10161 · Cited by 137
Loss of membranous Ep-CAM in budding colorectal carcinoma cells
Gosens, M. J. E. M., van Kempen, L. C. L. T., van de Velde, C. J. �., van Krieken, J. H., & Nagtegaal, I. D. (2007) · Modern Pathology · doi:10.1038/modpathol.3800733 · Cited by 120
Li, C.-Y., Li, B.-X., Liang, Y., Peng, R.-Q., Ding, Y., Xu, D.-Z., Zhang, X., Wan, D.-S., Wan, D. S., Zeng, Y.-X., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-56 · Cited by 102
Mezzanzanica, D., Fabbi, M., Bagnoli, M., Staurengo, S., Losa, M., Balladore, E., Alberti, P., Lusa, L., Ditto, A., Ferrini, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0428 · Cited by 91
A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer
Ngan, C. Y., Yamamoto, H., Seshimo, I., Ezumi, K., Terayama, M., Hemmi, H., Takemasa, I., Ikeda, M., Sekimoto, M., & Monden, M. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20638 · Cited by 73
Herrlich, P. A., Pals, S. T., & Ponta, H. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00252-e · Cited by 72
Mammary stem cell number as a determinate of breast cancer risk
Ginestier, C., & Wicha, M. S. (2007) · Breast Cancer Research · doi:10.1186/bcr1741 · Cited by 68
Cell Surface Molecules and Their Prognostic Values in Assessing Colorectal Carcinomas
Haier, J., Nasralla, M. Y., & Nicolson, G. L. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00003 · Cited by 66
CD44V6 expression in human colorectal carcinoma
Coppola, D., Hyacinthe, M., Fu, L., Cantor, A. B., Karl, R. C., Marcet, J. E., Cooper, D. L., Nicosia, S. V., & Cooper, H. S. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)80014-2 · Cited by 66
Expression of standard CD44 in human colorectal carcinoma: Association with prognosis
Huh, J. W., Kim, H. R., Kim, Y. J., Lee, J. H., Park, Y. S., Cho, S. H., & Joo, J. K. (2009) · Pathology International · doi:10.1111/j.1440-1827.2009.02357.x · Cited by 65
CD44 Splice Variants as Prognostic Markers in Colorectal Cancer
van der Voort, R. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850166257 · Cited by 54
Decreased expression of CD44 splicing variants in advanced colorectal carcinomas
Weg‐Remers, S., Anders, M., Lampe, B., Riecken, E. O., Schüder, G., Feifel, G., Zeitz, M., & Stallmach, A. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00177-4 · Cited by 31
Zlobec, I., Günthert, U., Tornillo, L., Iezzi, G., Baumhoer, D., Terracciano, L., & Lugli, A. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03421.x · Cited by 30
Self-citationPrince, S., Zeidman, A., Dekel, Y., Ram, E., & Koren, R. (2008) · American Journal of Clinical Pathology · doi:10.1309/h8jeeaeb69j3kynd · Cited by 27
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Tomita, H., Tanaka, K., Tanaka, T., & Hara, A. (2016) · Oncotarget · doi:10.18632/oncotarget.6920 · Cited by 595
The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
Ma, I., & Allan, A. L. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9208-4 · Cited by 539
Tumour budding in solid cancers
Lugli, A., Zlobec, I., Berger, M. D., Kirsch, R., & Nagtegaal, I. D. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0422-y · Cited by 366
Self-citationCancer stem cells: problems for therapy?
Alison, M. R., Lim, S. M., & Nicholson, L. J. (2011) · The Journal of Pathology · doi:10.1002/path.2793 · Cited by 312
Metadata
- Authors
- Lugli, A., Iezzi, G., Hostettler, I., Muraro, M. G., Mele, V, Tornillo, L., Carafa, V, Spagnoli, G., Terracciano, L., & Zlobec, I.
- Venue
- British Journal of Cancer
- Published
- 2010-07
- Volume
- 103
- Issue
- 3
- Pages
- 382-390
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1981401376
- Cited by
- 313
- References
- 41
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.